Press Room

As a global leader specializing in in vitro diagnostics for medical and industrial applications, bioMérieux is pleased to share information with members of the media.

bioMérieux in the Press

Managed Healthcare Executive Discusses New CMS Rule and the Role of Diagnostics in Antimicrobial Stewardship Programs
Triangle Business Journal Highlights Impact of new CMS Rules on AMR, Hospitals, and bioMérieux
bioMérieux in the Press: 360Dx

Recent Press Releases & News

bioMérieux Continues to Win Numerous Industry Awards for Outstanding Service and Performance
Launch of BIOFIRE^® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products
BIOFIRE^® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE marked
bioMérieux receives FDA clearance to extend platelet shelf life to 7 days with Large Volume Delayed Sampling strategy
bioMérieux serology tests for SARS-CoV-2 on VIDAS^® undergo validation preceding imminent launch
BIOFIRE^® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 obtains FDA Emergency Use Authorization
View More >

Americas Leadership Team

Brian Armstrong
- Ad Interim
- Executive Vice President
- Americas Region
Bart van den Brand
- Vice President
- Quality, Americas
- Region
Andrew Parker
- Vice President
- Corporate Business
- Development & Legal
- Americas Region
Erica Ruffin
- Vice President
- Human Resources
- Americas Region
Jana Inman
- Ad Interim
- Chief Financial Officer
- Americas Region
Antonio Santos
- Vice President
- Operations and
- Site Management
- Americas Region
Suzanne Jones
- Vice President
- Corporate Communications
- & Public Affairs
- Americas Region